AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

IMUGENE LIMITED Share Issue/Capital Change 2013

Jul 10, 2013

65124_rns_2013-07-10_aca16295-5910-472b-b9d1-8fe4e09e7404.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

==> picture [227 x 48] intentionally omitted <==

11 July 2013

ASX Announcement Release of Shares from Escrow

In accordance with ASX listing rule 3.10A, Imugene Limited advises that 100,000,000 ordinary shares will be released from escrow on 31 July 2013.

Ends

For more information please visit www.imugene.com .

Investor contact:

Dr Nick Ede, Imugene – 0400 642 254 / [email protected]

About Imugene

Imugene Limited (ASX:IMU) is commercialising drug delivery applications based on its novel buccal (drugs administered via the cheek) Linguet™ technology. Linguet™ is a patient friendly and cost effective system used to deliver established pharmaceutical and nutraceutical products.